TGFB1 and cancer: Similarly, the success of combining TGFβ inhibitors with immunotherapy in animal cancer models could not be replicated in human clinical trials probably reflecting the pleiotropic functions of TGFβ in normal fibroblasts9,58–60 or a compensatory increase in Activin A signaling upon inhibition of TGFβ15.